Northwestern Medicine recently joined a landmark clinical - TopicsExpress



          

Northwestern Medicine recently joined a landmark clinical trial—enrolling the first participant in the Midwest--to investigate if a vaccine made from a patient’s own brain tumor is effective in slowing tumor progression and extending survival. The largest randomized brain tumor vaccine trial ever funded by the National Cancer Institute, the study is chaired by Andrew Parsa, MD, PhD, who joined Northwestern in July as the chair of neurological surgery. Northwestern Brain Tumor Institute co-director, Jeffrey Raizer, MD, is the principal investigator for the trial at Northwestern. Contact information and a link to enrollment criteria on the Lurie Cancer Center website are included in this article, or call 312.695.2047 to learn more.
Posted on: Thu, 15 Aug 2013 18:40:08 +0000

Trending Topics



Recently Viewed Topics




© 2015